N. Chandrika Lakshmi's Insider Trades & SAST Disclosures
N. Chandrika Lakshmi's most recent trade in Divi's Laboratories Ltd. was a Acquisition of 32,178 Equity Shares done at an average price of Rs. 2806 . Disclosure was reported to the exchange on March 30, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for N. Chandrika Lakshmi in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | N. Chandrika Lakshmi | Immediate Relative | Acquisition | 30 Mar 2023 | 32,178 | 85,738 (0.03%) | 0.01% | 2806 | 90,291,468 | 29 Mar 2023 29 Mar 2023 |
Insider Trading | Equity Shares | Gift |
| Divi's Laboratories | N. Chandrika Lakshmi | Directors Immediate Relative | Acquisition | 25 Jun 2021 | 53,560 | 53,560 (0.02%) | 0.02% | 0 | 0 | 24 Jun 2021 24 Jun 2021 |
Insider Trading | Equity Shares | Gift |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.